Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients

ABSTRACT: Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients

PROVIDER: PRJNA598034 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [miRNA]

Project description:Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [miRNA]

| PRJNA598036 | ENA

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [mRNA]

Project description:Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [mRNA]

| PRJNA598037 | ENA

microRNA-expression profiling according to MN1 mRNA expression levels in de novo cytogenetically normal acute myeloid leukemia patients aged 60 years or older.

Project description:microRNA-expression profiling according to MN1 mRNA expression levels in de novo cytogenetically normal acute myeloid leukemia patients aged 60 years or older.

2011-10-20 | E-TABM-1190 | biostudies-arrayexpress

microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia patients 60 years.\//\<

Project description:microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia patients <60 years.

2012-06-09 | E-TABM-1166 | biostudies-arrayexpress

MicroRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia patients >=60 years.

Project description:MicroRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia patients >=60 years.

2012-06-09 | E-TABM-1167 | biostudies-arrayexpress

Gene-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia.

Project description:Gene-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia.

2012-06-09 | E-TABM-1165 | biostudies-arrayexpress

Gene-expression profiling according to MN1 mRNA expression levels in de novo cytogenetically normal acute myeloid leukemia patients aged 60 years or older.

Project description:Gene-expression profiling according to MN1 mRNA expression levels in de novo cytogenetically normal acute myeloid leukemia patients aged 60 years or older.

2011-10-20 | E-TABM-1189 | biostudies-arrayexpress

Gene Expression Signature Predicts Relapse in Adult Patients with Cytogenetically Normal Acute Myeloid Leukemia

Project description:Gene Expression Signature Predicts Relapse in Adult Patients with Cytogenetically Normal Acute Myeloid Leukemia

| PRJNA694617 | ENA

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [mRNA]

Project description:The study integrated both miRNA and mRNA profiles to explore novel miRNA-mRNA interactions that affect the regulatory patterns in de novo CN-AML. A total of 637 significant negative correlations (FDR <0.05) were reported. Network analysis revealed a cluster of 12 miRNAs that represents the majority of the mRNA targets. Within the cluster, five miRNAs; miR-495-3p, miR-185-5p, let-7i-5p, miR-409-3p, and miR-127-3p were suggested to play a pivotal role in the regulation of CN-AML as they are associated with negative regulation of myeloid leukocyte differentiation, negative regulation of myeloid cell differentiation, positive regulation of haematopoiesis, and hematopoiesis and its regulation. Three novel interactions in CN-AML were predicted, let-7i-5p:HOXA9, miR-495-3p:PIK3R1 and miR-495-3p:CDK6 which are responsible in regulating myeloid cell differentiation in CN-AML.

2019-12-30 | GSE142698 | GEO

Co-expression of microrna and mrna in cytogenetically normal acute myeloid leukemia patients [miRNA]

2019-12-30 | GSE142699 | GEO